Publication | Closed Access

First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A—results of a retrospective analysis

Lymphoid NeoplasiaMedicineFollicular LymphomaPathologyRetrospective AnalysisFirst-line TreatmentDermatologyOncologyRadiation Oncology